$84.95▴ 0.13%
End-of-day close · 2026-08-31
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Crinetics Pharmaceuticals, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Halper Sadeh LLC is Investigating Whether BZH, ACA, SYNA, CRNX are Obtaining Fair Deals for their Shareholders
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Why This Pharmaceutical Stock Jumped Close to 100% This Week